154 related articles for article (PubMed ID: 34659131)
1. Molecular Profile of a Pituitary Rhabdomyosarcoma Arising From a Pituitary Macroadenoma: A Case Report.
Lu J; Chen L
Front Endocrinol (Lausanne); 2021; 12():752361. PubMed ID: 34659131
[TBL] [Abstract][Full Text] [Related]
2. Primary Sellar Rhabdomyosarcoma Arising in Association With a Pituitary Adenoma.
Duncan VE; Nabors LB; Warren PP; Conry RM; Willey CD; Perry A; Riley KO; Hackney JR
Int J Surg Pathol; 2016 Dec; 24(8):753-756. PubMed ID: 27422470
[TBL] [Abstract][Full Text] [Related]
3. Sarcomatous transformation of pituitary adenoma after bromocriptine therapy.
Nagasaka T; Nakashima N; Furui A; Wakabayashi T; Yoshida J
Hum Pathol; 1998 Feb; 29(2):190-3. PubMed ID: 9490282
[TBL] [Abstract][Full Text] [Related]
4. Visual Defects in Patients With Pituitary Adenomas: The Myth of Bitemporal Hemianopsia.
Lee IH; Miller NR; Zan E; Tavares F; Blitz AM; Sung H; Yousem DM; Boland MV
AJR Am J Roentgenol; 2015 Nov; 205(5):W512-8. PubMed ID: 26496573
[TBL] [Abstract][Full Text] [Related]
5. Successful management of a pregnant woman with a TSH secreting pituitary adenoma with surgical and medical therapy.
Chaiamnuay S; Moster M; Katz MR; Kim YN
Pituitary; 2003 Sep; 6(2):109-13. PubMed ID: 14703021
[TBL] [Abstract][Full Text] [Related]
6. Gigantism with pituitary macroadenoma: an unusual variant of McCune-Albright syndrome.
Queirolo S; Gallarotti F; Capuano E; Garrè ML; Spaziante R; Di Battista E
J Pediatr Endocrinol Metab; 2009 Feb; 22(2):177-9. PubMed ID: 19449675
[No Abstract] [Full Text] [Related]
7. Evolution of postoperative pituitary adenoma resection cavities assessed by magnetic resonance imaging and implications regarding radiotherapy timing and modality.
Farnworth MT; Yuen KCJ; Chapple KM; Matthees NG; White WL; Little AS; Rogers L; Hughes JN
Clin Imaging; 2022 Feb; 82():110-116. PubMed ID: 34801841
[TBL] [Abstract][Full Text] [Related]
8. Osteogenic sarcoma of the sella after radiation treatment of a pituitary adenoma.
Bembo SA; Pasmantier R; Davis RP; Xiong Z; Weiss TE
Endocr Pract; 2004; 10(4):335-8. PubMed ID: 15760777
[TBL] [Abstract][Full Text] [Related]
9. Unusual case of a pituitary macroadenoma invading and encasing the optic track.
Hekha N; Sitoh YY; Hui FK
Singapore Med J; 2016 Jul; 57(7):410. PubMed ID: 27439617
[No Abstract] [Full Text] [Related]
10. Association of retinal nerve fibre layer thickness with quantitative magnetic resonance imaging data of the optic chiasm in pituitary adenoma patients.
Glebauskiene B; Liutkeviciene R; Zlatkute E; Kriauciuniene L; Zaliuniene D
J Clin Neurosci; 2018 Apr; 50():1-6. PubMed ID: 29398198
[TBL] [Abstract][Full Text] [Related]
11. Complete Response of a Patient With a Mismatch Repair Deficient Aggressive Pituitary Adenoma to Immune Checkpoint Inhibitor Therapy: A Case Report.
Shah S; Manzoor S; Rothman Y; Hagen M; Pater L; Golnik K; Mahammedi A; Lin AL; Bhabhra R; Forbes JA; Sengupta S
Neurosurgery; 2022 Aug; 91(2):e51-e56. PubMed ID: 35544035
[TBL] [Abstract][Full Text] [Related]
12. Optic nerve hyperintensity on T2-weighted images among patients with pituitary macroadenoma: correlation with visual impairment.
Tokumaru AM; Sakata I; Terada H; Kosuda S; Nawashiro H; Yoshii M
AJNR Am J Neuroradiol; 2006 Feb; 27(2):250-4. PubMed ID: 16484385
[TBL] [Abstract][Full Text] [Related]
13. Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation.
Syro LV; Sundsbak JL; Scheithauer BW; Toledo RA; Camargo M; Heyer CM; Sekiya T; Uribe H; Escobar JI; Vasquez M; Rotondo F; Toledo SP; Kovacs K; Horvath E; Babovic-Vuksanovic D; Harris PC
Pituitary; 2012 Sep; 15(3):342-9. PubMed ID: 21744088
[TBL] [Abstract][Full Text] [Related]
14. The identification of human pituitary adenoma-initiating cells.
Manoranjan B; Mahendram S; Almenawer SA; Venugopal C; McFarlane N; Hallett R; Vijayakumar T; Algird A; Murty NK; Sommer DD; Provias JP; Reddy K; Singh SK
Acta Neuropathol Commun; 2016 Nov; 4(1):125. PubMed ID: 27894339
[TBL] [Abstract][Full Text] [Related]
15. Somatic NF1 mutations in pituitary adenomas: Report of two cases.
Hong CS; Kundishora AJ; Elsamadicy AA; Koo AB; McGuone D; Inzucchi SE; Omay SB; Erson-Omay EZ
Cancer Genet; 2021 Aug; 256-257():26-30. PubMed ID: 33862521
[No Abstract] [Full Text] [Related]
16. Gonadotroph adenoma with secondary hypersecretion of testosterone.
Chamoun R; Layfield L; Couldwell WT
World Neurosurg; 2013 Dec; 80(6):900.e7-11. PubMed ID: 23201183
[TBL] [Abstract][Full Text] [Related]
17. [Pituitary melanocytoma mimicking an adenoma].
Coulibaly B; Bouvier C; Paula AM; Fernandez C; Dufour H; Figarella-Branger D
Ann Pathol; 2011 Feb; 31(1):50-2. PubMed ID: 21349390
[TBL] [Abstract][Full Text] [Related]
18. Radiation necrosis of the optic chiasm, optic tract, hypothalamus, and upper pons after radiotherapy for pituitary adenoma, detected by gadolinium-enhanced, T1-weighted magnetic resonance imaging: case report.
Tachibana O; Yamaguchi N; Yamashima T; Yamashita J
Neurosurgery; 1990 Oct; 27(4):640-3. PubMed ID: 2234373
[TBL] [Abstract][Full Text] [Related]
19. PTTG and Ki-67 expression in pituitary adenomas.
Wierzbicka-Tutka I; Sokołowski G; Bałdys-Waligórska A; Adamek D; Radwańska E; Gołkowski F
Przegl Lek; 2016; 73(2):53-8. PubMed ID: 27197423
[TBL] [Abstract][Full Text] [Related]
20. Surgery, Octreotide, Temozolomide, Bevacizumab, Radiotherapy, and Pegvisomant Treatment of an AIP Mutation‒Positive Child.
Dutta P; Reddy KS; Rai A; Madugundu AK; Solanki HS; Bhansali A; Radotra BD; Kumar N; Collier D; Iacovazzo D; Gupta P; Raja R; Gowda H; Pandey A; Devgun JS; Korbonits M
J Clin Endocrinol Metab; 2019 Aug; 104(8):3539-3544. PubMed ID: 31125088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
